Evaluating the HER-2 status of breast cancer using mammography radiomics features.

08:00 EDT 22nd October 2019 | BioPortfolio

Summary of "Evaluating the HER-2 status of breast cancer using mammography radiomics features."

The aim of our study was to evaluate the HER-2 status in breast cancer patients using mammography (MG) radiomics features.


Journal Details

This article was published in the following journal.

Name: European journal of radiology
ISSN: 1872-7727
Pages: 108718


DeepDyve research library

PubMed Articles [24921 Associated PubMed Articles listed on BioPortfolio]

Ultrasound-based radiomics nomogram: A potential biomarker to predict axillary lymph node metastasis in early-stage invasive breast cancer.

To establish a radiomics nomogram integrating clinical factors and radiomics features from ultrasound for the preoperative diagnosis axillary lymph node (ALN) status in patients with early-stage invas...

Factors Influencing Surveillance Mammography Adherence Among Breast Cancer Survivors.

Many breast cancer survivors fail to engage in surveillance mammography to detect new and recurrent cancers. This review identifies factors promoting or inhibiting breast cancer survivors' participati...

Non-Invasive MGMT Status Prediction in GBM Cancer Using Magnetic Resonance Images Radiomics Features: Univariate and Multivariate Radiogenomics Analysis.

This study aimed to predict methylation status of the O-6 methyl guanine-DNA methyl transferase (MGMT) gene promoter status by using MRI radiomics features, as well as univariate and multivariate anal...

A New Application of Multimodality Radiomics Improves Diagnostic Accuracy of Nonpalpable Breast Lesions in Patients with Microcalcifications-Only in Mammography.

BACKGROUND The aim of this study was to assess a radiomic scheme that combines image features from digital mammography and dynamic contrast-enhanced MRI to improve classification accuracy of nonpalpab...

Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.

China has an increasing burden of breast cancer. However, with a large population of dense breast patients, the diagnostic efficiency of conventional digital mammography is attenuated.

Clinical Trials [22318 Associated Clinical Trials listed on BioPortfolio]

Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective...

Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis ma...

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

This is a feasibility study to evaluate dual-energy (DE) contrast-enhanced (CE) digital mammography to detect breast cancer in patients with increased breast density (BI-RADS category c or...

Computed Tomography Laser Mammography Breast Imaging Device

The purpose of this study is to evaluate the sensitivity and specificity of the CTLM system when used adjunctively with mammography compared to mammography alone in the heterogeneously and...

Digital Breast Tomosynthesis Preference Study

Mammography remains the current standard in the detection of breast cancer. However, conventional two-view mammography will not detect all cancers. The major limiting factor of conventio...

Medical and Biotech [MESH] Definitions

Measurement of relative composition of different BREAST tissue types often determined from MAMMOGRAPHY; ULTRASONOGRAPHY; or MRI.

Abnormal accumulation of lymph in the arm, shoulder and breast area associated with surgical or radiation breast cancer treatments (e.g., MASTECTOMY).

Metastatic breast cancer characterized by EDEMA and ERYTHEMA of the affected breast due to LYMPHATIC METASTASIS and eventual obstruction of LYMPHATIC VESSELS by the cancer cells.

Radiographic examination of the breast.

A performance measure for rating the ability of a person to perform usual activities, evaluating a patient's progress after a therapeutic procedure, and determining a patient's suitability for therapy. It is used most commonly in the prognosis of cancer therapy, usually after chemotherapy and customarily administered before and after therapy. It was named for Dr. David A. Karnofsky, an American specialist in cancer chemotherapy.

Quick Search

DeepDyve research library

Relevant Topic

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...

Searches Linking to this Article